Inogen, Inc. (INGN)
USD 7.05
(-2.08%)
USD 7.05
(-2.08%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -109.38 Million USD | -437.46% |
| 2022 | 19.07 Million USD | 254.01% |
| 2021 | -12.38 Million USD | -3.02% |
| 2020 | -12.02 Million USD | -301.93% |
| 2019 | 5.95 Million USD | -84.28% |
| 2018 | 37.89 Million USD | 37.34% |
| 2017 | 27.59 Million USD | 20.67% |
| 2016 | 22.86 Million USD | 51.91% |
| 2015 | 15.05 Million USD | 43.19% |
| 2014 | 10.51 Million USD | 135.46% |
| 2013 | 4.46 Million USD | 438.48% |
| 2012 | 829 Thousand USD | 148.14% |
| 2011 | -1.72 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -15.46 Million USD | 30.59% |
| 2024 Q2 | -6.03 Million USD | 60.98% |
| 2023 FY | -64.38 Million USD | -437.46% |
| 2023 Q4 | -22.28 Million USD | 52.31% |
| 2023 Q3 | -46.72 Million USD | -297.02% |
| 2023 Q2 | -11.76 Million USD | 46.3% |
| 2023 Q1 | -21.91 Million USD | -147.81% |
| 2022 Q1 | -13.58 Million USD | -103.6% |
| 2022 Q3 | -10.29 Million USD | -257.86% |
| 2022 Q2 | -2.87 Million USD | 78.83% |
| 2022 FY | 19.07 Million USD | 254.01% |
| 2022 Q4 | 45.83 Million USD | 545.33% |
| 2021 Q1 | -2.13 Million USD | 61.39% |
| 2021 Q2 | 11.67 Million USD | 647.42% |
| 2021 FY | -12.38 Million USD | -3.02% |
| 2021 Q3 | 6.37 Million USD | -45.39% |
| 2021 Q4 | -6.67 Million USD | -204.69% |
| 2020 Q4 | -5.52 Million USD | -179.88% |
| 2020 FY | -12.02 Million USD | -301.93% |
| 2020 Q3 | -1.97 Million USD | 16.08% |
| 2020 Q2 | -2.35 Million USD | -7.89% |
| 2020 Q1 | -2.17 Million USD | 59.05% |
| 2019 Q1 | 4.85 Million USD | 1.74% |
| 2019 FY | 5.95 Million USD | -84.28% |
| 2019 Q4 | -5.32 Million USD | -165.63% |
| 2019 Q3 | 8.1 Million USD | -33.25% |
| 2019 Q2 | 12.14 Million USD | 150.0% |
| 2018 Q4 | 4.77 Million USD | -54.07% |
| 2018 FY | 37.89 Million USD | 37.34% |
| 2018 Q3 | 10.39 Million USD | -25.85% |
| 2018 Q2 | 14.02 Million USD | 61.16% |
| 2018 Q1 | 8.7 Million USD | 67.63% |
| 2017 FY | 27.59 Million USD | 20.67% |
| 2017 Q1 | 5.57 Million USD | -9.72% |
| 2017 Q2 | 8.49 Million USD | 52.52% |
| 2017 Q3 | 8.33 Million USD | -1.94% |
| 2017 Q4 | 5.19 Million USD | -37.71% |
| 2016 FY | 22.86 Million USD | 51.91% |
| 2016 Q1 | 3.27 Million USD | -5.67% |
| 2016 Q3 | 5.39 Million USD | -32.7% |
| 2016 Q4 | 6.17 Million USD | 14.34% |
| 2016 Q2 | 8.01 Million USD | 144.71% |
| 2015 Q2 | 5.34 Million USD | 112.27% |
| 2015 Q4 | 3.47 Million USD | -6.46% |
| 2015 Q3 | 3.71 Million USD | -30.51% |
| 2015 Q1 | 2.51 Million USD | 75.84% |
| 2015 FY | 15.05 Million USD | 43.19% |
| 2014 Q4 | 1.43 Million USD | -59.85% |
| 2014 Q2 | 3.96 Million USD | 155.84% |
| 2014 Q1 | 1.54 Million USD | 180.11% |
| 2014 Q3 | 3.56 Million USD | -9.99% |
| 2014 FY | 10.51 Million USD | 135.46% |
| 2013 Q1 | 633 Thousand USD | 210.29% |
| 2013 Q2 | 2.39 Million USD | 277.88% |
| 2013 FY | 4.46 Million USD | 438.48% |
| 2013 Q4 | 553 Thousand USD | -37.58% |
| 2013 Q3 | 886 Thousand USD | -62.96% |
| 2012 Q4 | 204 Thousand USD | -49.63% |
| 2012 Q3 | 405 Thousand USD | 0.0% |
| 2012 FY | 829 Thousand USD | 148.14% |
| 2011 FY | -1.72 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -661.688% |
| Cerus Corporation | -30.05 Million USD | -263.977% |
| OrthoPediatrics Corp. | -25.76 Million USD | -324.536% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -929.87% |
| Talis Biomedical Corporation | -66.81 Million USD | -63.715% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -532.435% |
| Spectral AI, Inc. | -12.98 Million USD | -742.468% |
| Nano-X Imaging Ltd. | -62.58 Million USD | -74.769% |
| CVRx, Inc. | -43.1 Million USD | -153.778% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -3000.51% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -780.158% |
| Orthofix Medical Inc. | -139.11 Million USD | 21.367% |
| Venus Concept Inc. | -28.3 Million USD | -286.4% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | -102.462% |
| Bioventus Inc. | -81.72 Million USD | -33.846% |
| BrainsWay Ltd. | -4.92 Million USD | -2120.134% |
| Envoy Medical, Inc. | -18.37 Million USD | -495.428% |
| electroCore, Inc. | -18.8 Million USD | -481.686% |
| IceCure Medical Ltd | -15.57 Million USD | -602.273% |
| Lucid Diagnostics Inc. | -48.48 Million USD | -125.622% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -533.46% |
| MaxCyte, Inc. | -48.29 Million USD | -126.477% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -814.962% |
| Nexalin Technology, Inc. | -5.69 Million USD | -1820.3% |
| PAVmed Inc | -68.79 Million USD | -59.003% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | -93.388% |
| RxSight, Inc. | -50.08 Million USD | -118.401% |
| Sight Sciences, Inc. | -57.27 Million USD | -90.987% |
| SI-BONE, Inc. | -46.93 Million USD | -133.078% |
| TELA Bio, Inc. | -44.07 Million USD | -148.182% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | -102.006% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | -112.697% |
| LivaNova PLC | -68.49 Million USD | -59.692% |
| 908 Devices Inc. | -42.75 Million USD | -155.826% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 36.915% |
| Nemaura Medical Inc. | -9.59 Million USD | -1040.003% |
| NeuroPace, Inc. | -27.17 Million USD | -302.539% |
| LENSAR, Inc. | -12.22 Million USD | -794.48% |
| Apyx Medical Corporation | -17.25 Million USD | -533.791% |
| Cutera, Inc. | -156.23 Million USD | 29.984% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -1171.339% |
| BioSig Technologies, Inc. | -28.51 Million USD | -283.649% |
| Anika Therapeutics, Inc. | -87.63 Million USD | -24.814% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | -387.33% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 198.081% |
| Axonics, Inc. | -26.05 Million USD | -319.795% |
| Outset Medical, Inc. | -169.77 Million USD | 35.568% |
| IRIDEX Corporation | -10 Million USD | -993.095% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | -0.198% |
| IRadimed Corporation | 20.03 Million USD | 645.962% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -1226.695% |
| INVO Bioscience, Inc. | -6.76 Million USD | -1516.425% |
| Telesis Bio, Inc. | -35.15 Million USD | -211.198% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 863.336% |
| Varex Imaging Corporation | 32.1 Million USD | 440.766% |
| Quipt Home Medical Corp. | 3.91 Million USD | 2891.171% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -801.558% |
| Pulmonx Corporation | -61.93 Million USD | -76.614% |
| Dynatronics Corporation | -2.27 Million USD | -4712.305% |
| Modular Medical, Inc. | -17.52 Million USD | -524.029% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -647.223% |
| Semler Scientific, Inc. | 22.25 Million USD | 591.49% |
| InMode Ltd. | 195.66 Million USD | 155.906% |
| Bruker Corporation | 436.9 Million USD | 125.037% |
| Cytosorbents Corporation | -31.2 Million USD | -250.492% |
| DexCom, Inc. | 597.7 Million USD | 118.301% |
| Align Technology, Inc. | 643.33 Million USD | 117.003% |
| Viveve Medical, Inc. | -21.55 Million USD | -407.521% |
| ZimVie Inc. | -30.93 Million USD | -253.554% |
| Movano Inc. | -29.69 Million USD | -268.427% |
| Cytek Biosciences, Inc. | -27.84 Million USD | -292.839% |
| Nexalin Technology, Inc. | -5.69 Million USD | -1820.3% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -3000.51% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 53.1% |
| Profound Medical Corp. | -28.61 Million USD | -282.255% |
| Insulet Corporation | 220 Million USD | 149.721% |
| enVVeno Medical Corporation | -25.23 Million USD | -333.418% |
| Surmodics, Inc. | -5.64 Million USD | -1837.75% |
| iCAD, Inc. | -7.68 Million USD | -1322.63% |
| Nuwellis, Inc. | -17.63 Million USD | -520.454% |
| Biotricity, Inc. | -8.82 Million USD | -1139.042% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 12.604% |
| Aethlon Medical, Inc. | -12.63 Million USD | -765.631% |
| InspireMD, Inc. | -21.14 Million USD | -417.363% |
| PAVmed Inc. | -68.79 Million USD | -59.003% |
| BIOLASE, Inc. | -17.93 Million USD | -509.834% |
| Beyond Air, Inc. | -63 Million USD | -73.612% |
| FONAR Corporation | 16.53 Million USD | 761.528% |
| AxoGen, Inc. | -21.46 Million USD | -409.673% |
| Vivani Medical, Inc. | -26.96 Million USD | -305.659% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 706.319% |
| Inari Medical, Inc. | -14.03 Million USD | -679.547% |
| UFP Technologies, Inc. | 57.66 Million USD | 289.695% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -2119.864% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -1634.697% |
| Tenon Medical, Inc. | -15.72 Million USD | -595.53% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -1363.554% |
| Co-Diagnostics, Inc. | -42.7 Million USD | -156.136% |
| AdaptHealth Corp. | -598.4 Million USD | 81.72% |
| Sintx Technologies, Inc. | -13.35 Million USD | -718.88% |
| NanoVibronix, Inc. | -3.43 Million USD | -3083.527% |
| Quanterix Corporation | -49.7 Million USD | -120.088% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -801.558% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -28535.079% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 67.295% |
| TransMedics Group, Inc. | -28.72 Million USD | -280.778% |
| ReWalk Robotics Ltd. | -23.61 Million USD | -363.264% |
| NeuroMetrix, Inc. | -7.15 Million USD | -1429.549% |
| Hyperfine, Inc. | -48.11 Million USD | -127.343% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | -68.219% |
| Biomerica, Inc. | -6.36 Million USD | -1618.015% |
| Bone Biologics Corporation | -9.42 Million USD | -1060.188% |
| AVITA Medical, Inc. | -40.4 Million USD | -170.743% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -960.845% |
| Silk Road Medical, Inc | -59.27 Million USD | -84.552% |